Literature DB >> 1993654

Reconstitution of the high affinity epidermal growth factor receptor on cell-free membranes after transmodulation by platelet-derived growth factor.

F Walker1, A W Burgess.   

Abstract

We have prepared plasma membranes from Balb/c 3T3 fibroblasts to study the transmodulation of the high affinity epidermal growth factor (EGF) receptor. Although phorbol esters do not transmodulate the high affinity EGF receptors on these membranes, the addition of platelet-derived growth factor (PDGF) or EGF to the membranes leads to the loss of high affinity EGF binding and to the phosphorylation of several membrane proteins, including the EGF receptor. The EGF receptor is phosphorylated at tyrosine residues although we have not yet established if this represents direct phosphorylation by the PDGF receptor kinase or is mediated by activation of other cell membrane-associated tyrosine kinases. Upon treatment of the membranes with PDGF, four major phosphoproteins (of apparent molecular masses of 69, 56, 38, and 28 kDa) are released from the membrane and can be retrieved from the supernatant fluid using a reversed-phase cartridge. As assessed by immunoprecipitation with an anti-phosphotyrosine antibody, all four proteins appear to be phosphorylated on tyrosine. The time course of dissociation of these proteins from the membranes closely parallels the loss of high affinity EGF receptors. The high affinity EGF receptor can be reconstituted on PDGF-transmodulated membranes by treating the supernatant fluid with alkaline phosphatase and adding the mixture to the membranes. It appears that dephosphorylation of the released proteins is sufficient to allow reassociation with the membranes and formation of the high affinity EGF receptor complex.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993654

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Cyclic stretch stimulates vascular smooth muscle cell alignment by redox-dependent activation of Notch3.

Authors:  Jian-Hong Zhu; Chun-Lin Chen; Sheila Flavahan; Jennifer Harr; Baogen Su; Nicholas A Flavahan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-12-17       Impact factor: 4.733

2.  Receptor heterodimerization: essential mechanism for platelet-derived growth factor-induced epidermal growth factor receptor transactivation.

Authors:  Y Saito; J Haendeler; Y Hojo; K Yamamoto; B C Berk
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

3.  Thermodynamic mixing of molecular states of the epidermal growth factor receptor modulates macroscopic ligand binding affinity.

Authors:  M R Holbrook; L L Slakey; D J Gross
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

4.  Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms.

Authors:  L E Johannessen; K E Haugen; A C østvold; E Stang; I H Madshus
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

5.  Cross talk among tyrosine kinase receptors in PC12 cells: desensitization of mitogenic epidermal growth factor receptors by the neurotrophic factors, nerve growth factor and basic fibroblast growth factor.

Authors:  I Mothe; R Ballotti; S Tartare; A Kowalski-Chauvel; E Van Obberghen
Journal:  Mol Biol Cell       Date:  1993-07       Impact factor: 4.138

6.  Affinity purification of plasma membranes.

Authors:  J deBlaquiere; A W Burgess
Journal:  J Biomol Tech       Date:  1999-06

7.  Systemic sclerosis immunoglobulin induces growth and a pro-fibrotic state in vascular smooth muscle cells through the epidermal growth factor receptor.

Authors:  Monique R Arts; Murray Baron; Nidaa Chokr; Marvin J Fritzler; Marc J Servant
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.